MedPath

University Hospital Tuebingen

πŸ‡©πŸ‡ͺGermany
Ownership
Private
Established
1388-01-01
Employees
-
Market Cap
-
Website
https://www.klinikum.uni-heidelberg.de/Startseite.2.0.html?&no_cache=1

Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease

Phase 2
Conditions
Arterial Occlusive Diseases
First Posted Date
2005-09-12
Last Posted Date
2006-09-12
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
420
Registration Number
NCT00156611
Locations
πŸ‡©πŸ‡ͺ

University of Tuebingen, Tuebingen, Germany

Thunder Trial - Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries

Phase 2
Conditions
Arterial Occlusive Diseases
First Posted Date
2005-09-12
Last Posted Date
2006-04-25
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
135
Registration Number
NCT00156624
Locations
πŸ‡©πŸ‡ͺ

University Hospital of Tuebingen, Tuebingen, Germany

Efficacy of Elidel Cream on Erosive Oral Lichen Planus

Phase 3
Completed
Conditions
Lichen Planus, Oral
First Posted Date
2005-08-15
Last Posted Date
2008-05-23
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
20
Registration Number
NCT00130572
Locations
πŸ‡©πŸ‡ͺ

University Hospital, Department of Dermatology, Tuebingen, Germany

Β© Copyright 2025. All Rights Reserved by MedPath